Announcements
On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc


In this issue


Home Eurosurveillance Edition  2017: Volume 22/ Issue 31 Article 3
Back to Table of Contents
Previous
Next

Eurosurveillance, Volume 22, Issue 31, 03 August 2017
Rapid communication
Litrup, Kiil, Hammerum, Roer, Nielsen, and Torpdahl: Plasmid-borne colistin resistance gene mcr-3 in Salmonella isolates from human infections, Denmark, 2009–17

+ Author affiliations


Citation style for this article: Litrup E, Kiil K, Hammerum AM, Roer L, Nielsen EM, Torpdahl M. Plasmid-borne colistin resistance gene mcr-3 in Salmonella isolates from human infections, Denmark, 2009–17. Euro Surveill. 2017;22(31):pii=30587. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2017.22.31.30587

Received:07 July 2017; Accepted:31 July 2017


In June 2017, Yin et al. reported a third plasmid-borne colistin resistance gene (encoded by mcr-3) in Escherichia coli from China [1]. The same study identified a truncated transposon element immediately upstream of mcr-3 that was also found in E. coli, Klebsiella pneumoniae and Salmonella Typhimurium [1]. This followed reports from 2016 on the plasmid-borne colistin resistance genes mcr-1 [2] and mcr-2 [3] and the subsequent reporting of global spread of mcr-1 and detection of mcr-1 from livestock/retail meat and human sources [4,5]. The worldwide spread of plasmid-mediated colistin resistance is of major concern, as colistin in some instances is the drug of last resort for multidrug-resistant infections.

Detection of mcr-3-positive human clinical isolates in Denmark

Statens Serum Institut (SSI) receives isolates (originating from stool, blood or urine samples) and patient information from all human clinical Salmonella infections for surveillance in Denmark. Since January 2017, all Salmonella isolates have been subjected to whole genome sequencing (WGS) in real time, in contrast to previous years where only a selection of isolates were sequenced. In a retrospective search for the truncated transposon and mcr-3 [1] among all Danish Salmonella isolates sequenced at SSI between 2009 and 2017 (ca 2,500), 10 Salmonella isolates were found positive for the mcr-3 gene; all isolates were ST34 and of serovar Typhimurium or monophasic variants of Typhimurium (4,5,12:i:- and 4,12:i:-) (Table). The years of disease onset recorded for the 10 Salmonella isolates were 2009 (n = 1), 2010 (n = 1), 2011 (n = 2), 2012 (n = 3), 2015 (n = 1), 2016 (n = 1) and 2017 (n = 1). Four of the patients had travelled to Thailand and one to Vietnam before onset of disease, three patients had unknown travel history and two patients had acquired their infection domestically (Table).

Table

Salmonella isolates positive for mcr-3, Denmark, 2009–17 (n=10)

Isolate Year of isolation Serotype Travel reported Inc type Resistance genes detected by ResFinder besides mcr-3
SSI-AC256 2009 Typhimurium None IncA/C2, ColRNAI aac(3)-IId, blaCTX-M-55, blaTEM-1B, catA2, floR, qnrS1, strA, strB, sul2, tet(A)
SSI-AC257 2010 O:4,5,12; H:i:- Unknown IncA/C2, ColRNAI aac(3)-IId, blaCTX-M-55, blaTEM-1B, floR, qnrS1, strA, strB, sul2, tet(A)
SSI-AC259 2011 O:4,5,12; H:i:- Thailand IncFII, IncQ1 aac(3)-IId, blaCTX-M-55, blaTEM-1B, catA2, qnrS1, strA, strB, sul2, tet(B)
SSI-AC258 2011 O:4,5,12; H:i:- Thailand IncA/C2 aac(3)-IId, blaCTX-M-55, blaTEM-1B, catA2, floR, qnrS1, strA, strB, sul2, tet(A)
SSI_AA940 2012 Typhimurium None ColRNAI aac(3)-IId, blaCTX-M-55, catA2, floR, qnrS1, strA, strB, sul2, tet(A)
SSI_AA992 2012 O:4,12; H:i: - Unknown IncHI2A, IncHI2, IncN, TrfA, IncQ1, ColRNAI aadA2, aph(3')-Ic, blaTEM-1B, dfrA12, strA, strB, sul1, sul2, tet(A), tet(B)
SSI_AA934 2012 Typhimurium Thailand IncA/C2, ColRNAI aac(3)-IId, blaCTX-M-55, blaTEM-1B, catA2, floR, qnrS1, strA, strB, sul2, tet(A)
SSI-AC260 2015 O:4,12; H:i: - Vietnam IncA/C2 blaCTX-M-55, blaTEM-1B, floR, strA, strB, sul2, tet(A)
SSI-AC261 2016 O:4,5,12; H:i:- Thailand IncFII(pCoo), IncX1, Col(MP18), IncQ1,ColRNAI blaTEM-1B, strA, strB, sul2, tet(B)
SSI-AC262 2017 O:4,12; H:i: - Unknown IncFIC(FII), IncI2, IncA/C2 blaCTX-M-55, blaTEM-1B, floR, mcr-1, strA, strB, sul2, tet(A)

Single-nucleotide polymorphism-based phylogeny

From WGS data (Illumina MiSeq) of the 10 mcr-3 positive isolates, extraction of sequences types (http://enterobase.warwick.ac.uk) assigned all isolates to ST34 (Table). The sequence data was used to create a single-nucleotide polymorphism (SNP) phylogeny using the Northern Arizona SNP Pipeline (NASP) [6], including local sequences representing the diversity within ST34 isolated from patients in Denmark with different travel histories (Figure). In total, 361 Salmonella isolates with serotypes Typhimurium and the monophasic variants of Typhimurium were included in the SNP analysis and the 10 mcr-3-positive isolates were located in two clades of the phylogeny (Figure). These two clades also contained most of the Salmonella isolates from patients with known travel history to Asia. Isolates from patients that had travelled in Europe, were domestically acquired or of unknown origin, were evenly distributed in the tree.

Figure

Phylogenetic tree calculated on core SNPs, including 361 isolates and 2,925 SNPs

/images/dynamic/articles/22848/17-00446-f1

SNP: single-nucleotide polymorphism.

Green nodes: mcr-3-positive isolates; blue nodes: isolates with confirmed patient travel to Asia.

Characterisation of isolates

Using ResFinder (https://cge.cbs.dtu.dk/services/ResFinder/), various resistance genes were detected in the WGS data (Table). The most prevalent resistance genes found in relation to the monophasic variant of Typhimurium, blaTEM − 1, strA-strB, sul2 and tet(A) or tet(B) [7] were detected in all mcr-3-positive isolates in this study. In addition, eight of the isolates carried blaCTX-M-55 and six isolates contained qnrS1, conferring low level resistance to fluoroquinolones [8]. Of note, one isolate from 2017 was positive to both mcr-1 and mcr-3 [2]. Using PlasmidFinder (https://cge.cbs.dtu.dk/services/PlasmidFinder/), several different replicons were detected (Table). One was IncHI2, the same as the plasmid-borne mcr-3 identified by Yin et al. on a 261-kb IncHI2-type plasmid (pWJ1) [1].

Discussion

The several recent publications that describe new plasmid-mediated colistin resistance [1-3] are of great concern and underline the importance of monitoring the spread of these plasmids worldwide [4,5]. In Denmark, mcr-1-positive isolates from human cases with Salmonella infection have been reported [9], whereas mcr-2 was not found among Danish isolates. This report describes 10 mcr-3-positive isolates from human Salmonella infections between 2009 and 2017. One of the isolates is especially relevant as it was positive for both mcr-1 and mcr-3 and to our knowledge a rare combination of two colistin resistance genes.

Eight of the MCR-3-producing Salmonella isolates from the Danish patients were also positive for blaCTX-M-55. CTX-M-55 was first reported from Thailand [10], and the blaCTX-M-55 gene is a prevalent gene in Gram-negative bacteria isolated from animals and humans in Asia [11-13]. Furthermore, blaCTX-M-55-positive monophasic Salmonella Typhimurium has been isolated from patients who reported travel to Thailand [14]. Several other studies have detected isolates with both mcr-1 and blaCTX-M-55, most of them also with a link to Asia [4,15]. Half of the Danish mcr-3-positive cases were linked with travel to Asia within one week before onset of disease. In general, the level of resistance in the Danish human cases of Salmonella Typhimurium and the monophasic variant is higher in cases with travel history than in domestically acquired cases [16].

One of the major concerns with the introduction of plasmid-borne colistin resistance is its ability of rapid horizontal spread between and within bacterial species; therefore plasmid spread could result in an increase in colistin-resistant bacteria. This in combination with the detection of MCR-3-producing isolates in patients without travel history is worrying because mcr-3 could in the future be present in food-borne outbreaks with Salmonella or E. coli.


Acknowledgements

We thank Christian Vråby Pedersen and Emine Yüksel Coskun for excellent technical assistance. We would also like to thank The Departments of Clinical Microbiology in Denmark for sending Salmonella isolates for the surveillance program.

The Danish Ministry of Health funded the project, as part of the National Surveillance of Foodborne Infections.

Conflict of interest

None declared.

Authors’ contributions

EL and KK did bioinformatic analysis and revised manuscript, AMH, LR and EMN gave scientific input and revised manuscript, MT designed, organised and drafted the manuscript.


References

  1. Yin W, Li H, Shen Y, Liu Z, Wang S, Shen Z,  et al.  Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. MBio. 2017;8(3):e00543-17. DOI: 10.1128/mBio.00543-17 PMID: 28655818

  2. Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J,  et al.  Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161-8. DOI: 10.1016/S1473-3099(15)00424-7 PMID: 26603172

  3. Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H,  et al.  Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill. 2016;21(27):30280. DOI: 10.2807/1560-7917.ES.2016.21.27.30280 PMID: 27416987

  4. Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds.Euro Surveill. 2016;21(9):30155. DOI: 10.2807/1560-7917.ES.2016.21.9.30155 PMID: 26967914

  5. Giamarellou H. Epidemiology of infections caused by polymyxin-resistant pathogens.Int J Antimicrob Agents. 2016;48(6):614-21. . Available from: https://doi.org/10.1016/j.ijantimicag.2016.09.025DOI: 10.1016/j.ijantimicag.2016.09.025 PMID: 27865627

  6. Sahl JW, Lemmer D, Travis J, Schupp JM, Gillece JD, Aziz M,  et al.  NASP: an accurate, rapid method for the identification of SNPs in WGS datasets that supports flexible input and output formats. Microb Genom. 2016;2(8):e000074. DOI: 10.1099/mgen.0.000074 PMID: 28348869

  7. García P, Malorny B, Rodicio MR, Stephan R, Hächler H, Guerra B,  et al.  Horizontal Acquisition of a Multidrug-Resistance Module (R-type ASSuT) Is Responsible for the Monophasic Phenotype in a Widespread Clone of Salmonella Serovar 4,[5],12:i. Front Microbiol. 2016;7:680. DOI: 10.3389/fmicb.2016.00680 PMID: 27242707

  8. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance.Lancet Infect Dis. 2006;6(10):629-40. DOI: 10.1016/S1473-3099(06)70599-0 PMID: 17008172

  9. Torpdahl M, Hasman H, Litrup E, Skov RL, Nielsen EM, Hammerum AM. Detection of mcr-1-encoding plasmid-mediated colistin-resistant Salmonella isolates from human infection in Denmark.Int J Antimicrob Agents. 2017;49(2):261-2. DOI: 10.1016/j.ijantimicag.2016.11.010 PMID: 28081925

  10. Kiratisin P, Apisarnthanarak A, Saifon P, Laesripa C, Kitphati R, Mundy LM. The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand.Diagn Microbiol Infect Dis. 2007;58(3):349-55. DOI: 10.1016/j.diagmicrobio.2007.02.005 PMID: 17449211

  11. Hoang TAV, Nguyen TNH, Ueda S, Le QP, Tran TTN, Nguyen TND,  et al.  Common findings of bla CTX-M-55-encoding 104-139 kbp plasmids harbored by extended-spectrum β-lactamase-producing Escherichia coli in pork meat, wholesale market workers, and patients with urinary tract infection in Vietnam. Curr Microbiol. 2017;74(2):203-11. DOI: 10.1007/s00284-016-1174-x PMID: 27942843

  12. Trongjit S, Angkititrakul S, Tuttle RE, Poungseree J, Padungtod P, Chuanchuen R. Prevalence and antimicrobial resistance in Salmonella enterica isolated from broiler chickens, pigs and meat products in Thailand-Cambodia border provinces.Microbiol Immunol. 2017;61(1):23-33. DOI: 10.1111/1348-0421.12462 PMID: 28042666

  13. Zheng H, Zeng Z, Chen S, Liu Y, Yao Q, Deng Y,  et al.  Prevalence and characterisation of CTX-M β-lactamases amongst Escherichia coli isolates from healthy food animals in China. Int J Antimicrob Agents. 2012;39(4):305-10. . Available from: https://doi.org/10.1016/j.ijantimicag.2011.12.001DOI: 10.1016/j.ijantimicag.2011.12.001 PMID: 22325120

  14. Gallati C, Stephan R, Hächler H, Malorny B, Schroeter A, Nüesch-Inderbinen M. Characterization of Salmonella enterica subsp. enterica serovar 4,[5],12:i:- clones isolated from human and other sources in Switzerland between 2007 and 2011.Foodborne Pathog Dis. 2013;10(6):549-54. DOI: 10.1089/fpd.2012.1407 PMID: 23614800

  15. Sun J, Li X-P, Yang R-S, Fang L-X, Huo W, Li S-M,  et al.  Complete Nucleotide Sequence of an IncI2 Plasmid Coharboring blaCTX-M-55 and mcr-1. Antimicrob Agents Chemother. 2016;60(8):5014-7. DOI: 10.1128/AAC.00774-16 PMID: 27216063

  16. Bager F, Bortolaia V, Ellis-Iversen J, Hendriksen RS, Borck Høg B, Bogø Jensen L, et al. DANMAP 2015. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. Søborg: National Food Institute and Copenhagen: Statens Serum Institut; 2016. Available from: http://www.danmap.org/~/media/Projekt sites/Danmap/DANMAP reports/DANMAP 2015/DANMAP 2015.ashx



Back to Table of Contents
Previous
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.